Peter J. Rossi

970 total citations
38 papers, 666 citations indexed

About

Peter J. Rossi is a scholar working on Pulmonary and Respiratory Medicine, Radiation and Surgery. According to data from OpenAlex, Peter J. Rossi has authored 38 papers receiving a total of 666 indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Pulmonary and Respiratory Medicine, 15 papers in Radiation and 9 papers in Surgery. Recurrent topics in Peter J. Rossi's work include Prostate Cancer Diagnosis and Treatment (33 papers), Prostate Cancer Treatment and Research (31 papers) and Advanced Radiotherapy Techniques (15 papers). Peter J. Rossi is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (33 papers), Prostate Cancer Treatment and Research (31 papers) and Advanced Radiotherapy Techniques (15 papers). Peter J. Rossi collaborates with scholars based in United States, Canada and India. Peter J. Rossi's co-authors include Ashesh B. Jani, Viraj A. Master, David M. Schuster, Mark M. Goodman, Raghuveer Halkar, Peter T. Nieh, Bital Savir-Baruch, Peter A.S. Johnstone, David L. McCullough and Jonathon A. Nye and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and Cancer.

In The Last Decade

Peter J. Rossi

35 papers receiving 652 citations

Peers

Countries citing papers authored by Peter J. Rossi

Since Specialization

Citations

This map shows the geographic impact of Peter J. Rossi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter J. Rossi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter J. Rossi more than expected).

Fields of papers citing papers by Peter J. Rossi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter J. Rossi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter J. Rossi. The network helps show where Peter J. Rossi may publish in the future.

Co-authorship network of co-authors of Peter J. Rossi

This figure shows the co-authorship network connecting the top 25 collaborators of Peter J. Rossi. A scholar is included among the top collaborators of Peter J. Rossi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter J. Rossi. Peter J. Rossi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	High-dose-rate (HDR) brachytherapy boost in combination with external beam radiotherapy for localized prostate cancer: An evidence-based consensus statement 2025 ·Brachytherapy ·Sagar A. Patel, Marisa Kollmeier, Juanita Crook, Daniel Krauss, Gerard Morton, Albert J. Chang, Joelle Helou, I‐Chow Hsu, Cynthia Ménard, Shyamal Patel, Tyler P. Robin, Peter J. Rossi, Michael J. Zeléfsky, Mitchell Kamrava	0
2	Association of Brachytherapy Boost with Overall Survival for Gleason 9-10 Prostate Cancer: The Impact of Primary versus Secondary Pattern 5 2023 ·Brachytherapy ·Sagar A. Patel, Brian C. Baumann, Jeff M. Michalski, Randall Brenneman, (unknown), Hiram A. Gay, D.J. Ferraro, Simon Brown, Albert J. Chang, Peter J. Rossi, Benjamin W. Fischer‐Valuck	2
3	Evaluation of burnout in physician members of the American Brachytherapy Society 2022 ·Brachytherapy ·Anthony T. Nguyen, (unknown), Mira Keyes, Daniel G. Petereit, Firas Mourtada, Peter J. Rossi, Ann H. Klopp, Mitchell Kamrava	1
4	Randomized Trial of Conventional Versus Conventional Plus Fluciclovine (18F) Positron Emission Tomography/Computed Tomography–Guided Postprostatectomy Radiation Therapy for Prostate Cancer: Volumetric and Patient-Reported Analyses of Toxic Effects 2022 ·International Journal of Radiation OncologyBiologyPhysics ·Vishal R. Dhere, David M. Schuster, Subir Goyal, Eduard Schreibmann, Bruce Hershatter, Peter J. Rossi, Joseph W. Shelton, Pretesh Patel, Ashesh B. Jani	2
5	Hydrogel spacers and prostate brachytherapy 2021 ·Brachytherapy ·Peter J. Rossi, David M. Marcus, William A. Hall, (unknown)	1
6	18F-fluciclovine-PET/CT imaging versus conventional imaging alone to guide postprostatectomy salvage radiotherapy for prostate cancer (EMPIRE-1): a single centre, open-label, phase 2/3 randomised controlled trial 2021 ·The Lancet ·Ashesh B. Jani, Eduard Schreibmann, Subir Goyal, Raghuveer Halkar, Bruce Hershatter, Peter J. Rossi, Joseph W. Shelton, Pretesh Patel, Karen M. Xu, Mark M. Goodman, Viraj A. Master, Shreyas Joshi, Ömer Küçük, Bradley Curtis Carthon, Mehmet Asım Bilen, (unknown), Akinyemi A. Akintayo, Vishal R. Dhere, David M. Schuster	103
7	Low dose rate brachytherapy for primary treatment of localized prostate cancer: A systemic review and executive summary of an evidence-based consensus statement 2021 ·Brachytherapy ·Martin T. King, Mira Keyes, Steven J. Frank, Juanita Crook, Wayne M. Butler, Peter J. Rossi, Brett Cox, Timothy N. Showalter, Firas Mourtada, Louis Potters, Richard G. Stock, Marisa Kollmeier, Michael J. Zeléfsky, Brian J. Davis, (unknown), Peter F. Orio	29
8	Overall survival comparison between androgen deprivation therapy (ADT) plus external beam radiation therapy (EBRT) vs ADT plus EBRT with brachytherapy boost in clinically node-positive prostate cancer 2020 ·Brachytherapy ·Benjamin W. Fischer‐Valuck, Yuan James Rao, Randall Brenneman, Pretesh Patel, Christopher P. Filson, Ashesh B. Jani, Yuan Liu, Subir Goyal, (unknown), (unknown), Ömer Küçük, Cara Cimmino, (unknown), Peter J. Rossi, Brian C. Baumann, John Pattaras, Bruce Hershatter, Sagar A. Patel	2
9	The American Brachytherapy Society prostate brachytherapy LDR/HDR simulation workshops: Hands-on, step-by-step training in the process of quality assurance 2020 ·Brachytherapy ·Steven J. Frank, Firas Mourtada, Juanita Crook, Peter F. Orio, Richard G. Stock, Daniel G. Petereit, Peter J. Rossi, Brett Cox, Chad Tang, Rajat J. Kudchadker, Teresa L. Bruno, Jingfei Ma, Jeremiah Sanders, Mira Keyes	11
10	Initial Report of a Randomized Trial Comparing Conventional- vs Conventional plus Fluciclovine (18F) PET/CT Imaging-Guided Post-Prostatectomy Radiotherapy for Prostate Cancer 2020 ·International Journal of Radiation OncologyBiologyPhysics ·(unknown), Eduard Schreibmann, Sharad Goyal, (unknown), Bruce Hershatter, Peter J. Rossi, (unknown), Pretesh Patel, Karen M. Xu, Mark M. Goodman, Viraj A. Master, Shreyas Joshi, (unknown), Bradley Curtis Carthon, Mehmet Asım Bilen, (unknown), (unknown), (unknown), Vishal R. Dhere, David M. Schuster	9
11	Prospective evaluation of fluciclovine ( 18 F) PET-CT and MRI in detection of recurrent prostate cancer in non-prostatectomy patients 2018 ·European Journal of Radiology ·Oladunni Akin-Akintayo, Funmilayo Tade, Pardeep Mittal, Courtney C. Moreno, Peter T. Nieh, Peter J. Rossi, Dattatraya Patil, Raghuveer Halkar, Baowei Fei, Viraj A. Master, Ashesh B. Jani, Hiroumi D. Kitajima, Adeboye O. Osunkoya, (unknown), Mark M. Goodman, David M. Schuster	27
12	Impact of ¹⁸F-Fluciclovine PET on Target Volume Definition for Postprostatectomy Salvage Radiotherapy: Initial Findings from a Randomized Trial 2016 ·Journal of Nuclear Medicine ·Ashesh B. Jani, Eduard Schreibmann, Peter J. Rossi, Joseph W. Shelton, Karen D. Godette, Peter T. Nieh, Viraj A. Master, Ömer Küçük, Mark M. Goodman, Raghuveer Halkar, (unknown), Zhengjia Chen, David M. Schuster	30
13	Recurrent prostate cancer detection with anti-3-[18F]FACBC PET/CT: comparison with CT 2016 ·European Journal of Nuclear Medicine and Molecular Imaging ·Oluwaseun Odewole, Funmilayo Tade, Peter T. Nieh, Bital Savir-Baruch, Ashesh B. Jani, Viraj A. Master, Peter J. Rossi, Raghuveer Halkar, Adeboye O. Osunkoya, Oladunni Akin-Akintayo, Chao Zhang, Zhengjia Chen, Mark M. Goodman, David M. Schuster	117
14	The association between C‐reactive protein (CRP) level and biochemical failure‐free survival in patients after radiation therapy for nonmetastatic adenocarcinoma of the prostate 2013 ·Cancer ·William A. Hall, Dana Nickleach, Viraj A. Master, Roshan S. Prabhu, Peter J. Rossi, Karen D. Godette, Sherri R. Cooper, Ashesh B. Jani	29
15	Prostate Cancer Modality Time Trend Analyses From 1973 to 2004 2010 ·American Journal of Clinical Oncology ·Ashesh B. Jani, Peter A.S. Johnstone, Stanley L. Liauw, Viraj A. Master, Peter J. Rossi	23
16	A Surveillance, Epidemiology, and End Results Registry Analysis of Prostate Cancer Modality Time Trends by Age 2010 ·American Journal of Clinical Oncology ·(unknown), Peter J. Rossi, Stanley L. Liauw, Peter A.S. Johnstone, Ashesh B. Jani	12
17	Pelvic Shape and Prostate Motion 2009 ·American Journal of Clinical Oncology ·Ashesh B. Jani, Timothy Fox, (unknown), Peter J. Rossi, Peter A.S. Johnstone, Viraj A. Master	1
18	A Simple Model Predicts Freedom From Biochemical Recurrence After Low-Dose Rate Prostate Brachytherapy Alone 2007 ·American Journal of Clinical Oncology ·Michael A. Papagikos, Peter J. Rossi, James J. Urbanic, Allan F. deGuzman, David L. McCullough, Peter E. Clark, W. Robert Lee	3
19	Percentage of positive biopsies associated with freedom from biochemical recurrence after low-dose-rate prostate brachytherapy alone for clinically localized prostate cancer 2006 ·Urology ·Peter J. Rossi, Peter E. Clark, Michael A. Papagikos, David L. McCullough, W. Robert Lee	15
20	Dosimetric quantifiers for low-dose-rate prostate brachytherapy: Is V100 superior to D90? 2005 ·Brachytherapy ·Michael A. Papagikos, Allan F. deGuzman, Peter J. Rossi, David L. McCullough, Peter E. Clark, W. Robert Lee	45

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact